Clinical Trials Directory

Trials / Unknown

UnknownNCT03877159

Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Guy's and St Thomas' NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Control of cell death is frequently disrupted in cancer resulting in overgrowth of tumour cells. Caspase-8 is a key enzyme involved in controlling cell death. This study examines the importance of caspase-8 in oral cancer.

Detailed description

Control of cell death is frequently disrupted in cancer resulting in overgrowth of tumour cells. The caspase family of enzymes are the key performers of controlled cell death and caspase-8 is frequently mutated in oral cancer. This study will perform DNA sequencing to determine if the gene is wild-type (not mutated). The abundance of inactive (uncleaved) and active (cleaved) caspase-8 will be determined. The levels of the proteins that caspase-8 interacts with (including caspase-3) will be determined. Results will be correlated with tumour stage, patient outcome and the presence of immune cells and other microscopic features. This will improve the understanding of the importance of caspase-8 in oral cancer.

Conditions

Interventions

TypeNameDescription
OTHERThere is no intervention.There is no intervention. This is a retrospective study analysing archived tumour samples.

Timeline

Start date
2017-11-11
Primary completion
2021-01-30
Completion
2021-01-30
First posted
2019-03-15
Last updated
2020-07-22

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03877159. Inclusion in this directory is not an endorsement.